INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
Explore Our Programs
Biomedical Science Research
STOPPING A GLOBAL KILLER
FIGHTING DISEASE THREATS
While humans have encountered some deadly viruses over the centuries such as influenza, Ebola, smallpox, SARS, MERS and HIV, there are inevitably new, life-threatening diseases out there waiting to emerge. Experts have agreed that it wasn’t a question of if – but when – another lethal infectious agent would occur and speculated if the world would be ready to fight it. Sadly, the answer is no.
News Stories & Events
More
Top Stories
Junior Biomedical Science and Enterprise Major Has Heart for Research
Gem Johnson has continued her cardiovascular research during the pandemic, even though she hasn’t been able to enter the lab.read more ❯
Biomedical Sciences Researcher Receives $2 Million Federal Grant To Study How Inflammation, Altered Gut Microbiota Promote Metabolic Syndrome
Dr. Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year federal grant just over $2 million to study how inflammation and altered gut microbiota, the microorganisms living in the intestine, influence the development of a group of diseases referred to as metabolic syndrome. read more ❯
Oral Drug Blocks SARS-CoV-2 Transmission, Georgia State Biomedical Sciences Researchers Find
Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.read more ❯